Back to search
FDAFDA · Food and drugs·Recall number D-0169-2025

Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01

Published January 8, 2025 · Recall initiated: December 16, 2024

Summary

FDA records drug Class III recall D-0169-2025, published January 8, 2025 and initiated December 16, 2024. Recalling firm: SOMERSET THERAPEUTICS LLC; Status: Terminated; Reported quantity: 5,870 bottles; Lot: Lot #: A240211, Exp. Date April 2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if ATROPINE SULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATROPINE SULFATE
Manufacturer
SOMERSET THERAPEUTICS LLC
Distributor
Nationwide within the United States
UPC
0370069716014
Lot
Lot #: A240211, Exp. Date April 2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01 recalled?

Yes. FDA published recall D-0169-2025 on January 8, 2025. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATROPINE SULFATE. UPC: 0370069716014.